ScholarIQanswers from OpenAlex & ORCID
Thomas J. Quinn
ResearcherPublications, citations & collaboration network
Thomas J. Quinn is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas J. Quinn have?
ScholarIQindexed works
Thomas J. Quinn has 105 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas J. Quinn have?
ScholarIQcitation count
Thomas J. Quinn has 676 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas J. Quinn?
ScholarIQh-index
Thomas J. Quinn has an h-index of 15 in OpenAlex.
What is the i10-index of Thomas J. Quinn?
ScholarIQi10-index
Thomas J. Quinn has an i10-index of 23 in OpenAlex.
What is the ORCID of Thomas J. Quinn?
ScholarIQorcid
The ORCID for Thomas J. Quinn is on the source record.
What is the OpenAlex record for Thomas J. Quinn?
ScholarIQopenalex
The OpenAlex for Thomas J. Quinn is on the source record.
What are the most-cited papers on Thomas J. Quinn?
ScholarIQmost cited works
Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy
Muayad F. Almahariq, Ronald Levitin, Thomas J. Quinn, Peter Y. Chen, Nayana Dekhne, Sayee Kiran, Amita A. Desai, Pamela Benitez, M.S. Jawad, G.S. Gustafson, J.T. Dilworth
Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer
Muayad F. Almahariq, Thomas J. Quinn, Z.A. Siddiqui, M.S. Jawad, Peter Y. Chen, G.S. Gustafson, J.T. Dilworth
Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma
Muayad F. Almahariq, Thomas J. Quinn, Pravin Kesarwani, Shiva Kant, C. Ryan Miller, Prakash Chinnaiyan
Very low density lipoproteins (VLDL) trigger the release of histamine from human basophils
B. Gonen, Phillip O'Donnell, T J Post, Thomas J. Quinn, Edward S. Schulman
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis
Thomas J. Quinn, Muayad F. Almahariq, Z.A. Siddiqui, A. Thompson, Daniel A. Hamstra, Peyman Kabolizadeh, Kate Gowans, Peter Y. Chen